3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

CSL Ltd (ASX: CSL) shares are down 1.4% in Wednesday afternoon trade. At the time of writing, the beaten-down biotech stock is trading at $139.13 per share.

Today's decline means the shares are now down 19% year to date and 44% over the year.

The company has faced significant headwinds recently, including lacklustre financial results, a shock CEO exit, and a surprise restructure announcement. CSL also downgraded its FY26 revenue and profit growth guidance in October, pushing its share price further south.

While the past 18 months have been filled with doom and gloom, I still see some great potential in CSL going forward. 

Here are three reasons why adding CSL shares to your portfolio today could be a great idea.

Scientists working in the laboratory and examining results.

Image source: Getty Images

1. There is huge and recurring demand for its products

CSL is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines. At the core of its business are its plasma-derived medicines, including immunoglobulins, albumin, and clotting factors. The company's blood plasma division dominates the market for rare blood disorders and immunoglobulin products. 

Demand for plasma therapies is strong and growing, driven by recurring demand, limited competition, and supply constraints. Recent reports indicate that demand for blood plasma derivatives was around 145 million litres in 2025 and is expected to increase significantly in 2026. The market was valued at $52.16 billion in 2025, and by 2033, it is expected to reach $104.30 billion.

2. The business is building momentum

CSL is one of the world's largest biotech companies, and despite short‑term headwinds, earnings momentum is expected to keep building. CSL has experienced periods of double‑digit profit growth, and its forecasts underpin a longer‑term recovery.

Sequoia Wealth Management's Peter Day, who has a buy recommendation on CSL shares, recently pointed out that the company has posted a significant increase in revenue during the past three years and delivered earnings growth that is compounding at double-digit rates.

3. Analysts are very bullish

Analysts are bullish about the outlook for CSL shares over the next 12 months. Many say the investor sell-off was way overdone and unwarranted.

TradingView data shows that 12 out of 18 analysts currently have a buy or strong buy rating on the stock. The average target price is $207.6, which implies a 50% upside at the time of writing. However, some think the share price could storm even higher, by 95% to $270.01 a piece.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A young well-dressed couple at a luxury resort celebrate successful life choices.
Opinions

My 3 biggest ASX portfolio winners and the one I'm buying more of

These businesses have significant growth potential.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »

Man with his hands out as if pondering his options.
Opinions

I've always loved Wesfarmers shares. But after a trip to Kmart, I'm not so sure

A weekend trip took some gloss off this stock.

Read more »

Piles of increasing coins alongside an hourglass.
Opinions

Why I'm planning to buy more Soul Patts shares in 2027

I think Soul Patts is a great long-term buy.

Read more »

a close up of a woman's face looks skywards as she is showered in a sea of graphic symbols of gold and silver coins bearing the bitcoin logo.
Cryptocurrencies

Are you a 'greater fool' for owning Bitcoin?

Is Bitcoin truly an investment?

Read more »

A woman in a red dress holding up a red graph.
Opinions

I went looking for shares which could double by 2030. These 3 made my shortlist

All of these shares are in recovery mode.

Read more »